VENTYX BIOSCIENCES, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • September 29th, 2021 • Ventyx Biosciences, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (this “Agreement”) is dated as of [insert date], and is between Ventyx Biosciences, Inc., a Delaware corporation (the “Company”), and [insert name of indemnitee] (“Indemnitee”).
VENTYX BIOSCIENCES, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT September 9, 2021Investors’ Rights Agreement • September 29th, 2021 • Ventyx Biosciences, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of September 9, 2021, by and among Ventyx Bioscience, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor.”
SHARE PURCHASE AGREEMENTShare Purchase Agreement • September 29th, 2021 • Ventyx Biosciences, Inc. • Pharmaceutical preparations • Delaware
This SHARE PURCHASE AGREEMENT (the “Agreement”) is made as of February 26, 2021, by and among Ventyx Biosciences, Inc., a Delaware corporation (the “Purchaser”), Zomagen Biosciences Ltd., a private company limited by shares, incorporated and registered in England and Wales with company number 11475190 whose registered office is at 125 Wood Street, London, EC2V 7AW (the “Company”), the Shareholders (as defined below) and listed on the signature pages hereto under “Shareholders”, the Noteholders (as defined below) and listed on the signature pages hereto under “Noteholders” and the SAFE Holders (as defined below) and listed on the signature pages hereto under “SAFE Holders” (the Shareholders, the Noteholders and the SAFE Holders shall be collectively referred to as the “Securityholders” and each, a “Securityholder”). The Purchaser, the Company, and the Securityholders, are sometimes referred to individually as a “Party” and collectively as the “Parties.” Certain capitalized terms that ar
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • September 29th, 2021 • Ventyx Biosciences, Inc. • Pharmaceutical preparations • California
This Asset Purchase Agreement (this “Agreement”), dated as of February 7, 2019 (the “Effective Date”), is entered into between Vimalan Biosciences, Inc., a Delaware corporation (“Seller”) and Ventyx Biosciences, Inc., a Delaware corporation (“Buyer”).
